Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer (opens in a new tab)
CompletedPhase 3
Breast NeoplasmsBreast DiseasesLetrozoleRibociclib
Dr. Tarek Eldawy, MD
NPI1669416459PAC ID3476556887
- Medicare services, 2024
- 66,340
- Medicare patients, 2024
- 848
- Part D claims, 2024
- 1,066
- Clinical trials
- 2
- Hospital affiliations
- 2
- Practice address
- 1708 Cape Coral W Pkwy, Cape Coral, FL 33914
- Practice phone
- Call (239) 541-4633
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Florida Cancer Specialists & Research Institute - Cape Coral Cay West
Cape Coral, Florida
Find Dr. Eldawy's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Tarek Eldawy is a medical oncologist in Cape Coral, Florida
Dr. Eldawy practices at Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida.
Dr. Eldawy's NPI, 1669416459, was assigned on June 15, 2006. Dr. Eldawy graduated from Alexandria University Faculty of Medicine in 1989. Dr. Eldawy holds Florida license ME94574.
NPI and contact details
- NPI
- 1669416459NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3476556887
- NPI enumeration date
- June 15, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (239) 541-4633
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 63
- Medical school graduation
- 1989
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Tarek Eldawy practices at Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida
Dr. Eldawy's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West, at 1708 Cape Coral W Pkwy, Cape Coral, FL 33914 in Lee County. The practice phone is (239) 541-4633.
- Florida Cancer Specialists & Research Institute - Cape Coral Cay West1708 Cape Coral W Pkwy, Cape Coral, FL 33914 · Lee CountyPhone(239) 541-4633
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Tarek Eldawy is affiliated with 7 sites of care and 4 medical groups
Dr. Eldawy's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida. Dr. Eldawy is also affiliated with AdventHealth Orlando. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Eldawy to 1 more hospital, 4 group practices and clinics and 3 medical groups, each named with a free account.
Florida Cancer Specialists & Research Institute - Cape Coral Cay WestPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Tarek Eldawy's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eldawy practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Florida Cancer Specialists & Research Institute - Cape Coral Cay West | Available with a free account |
| +6 more sites and 3 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Eldawy practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Tarek Eldawy is one of 477 medical oncologists in Florida
Medical oncology is Dr. Eldawy's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Eldawy is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Eldawy's licenses on file in 2 states: Florida and Michigan.
Specialties and state licenses
- Medical oncology, FloridaPrimary
- Michigan license
Clinical focus
Dmand AI lists anemia, breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT) and fluid and electrolyte imbalances among the conditions Dr. Eldawy treats.
Medical oncologists near Dr. Eldawy
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Tarek Eldawy billed Medicare for 66,340 services in 2024
CMS data shows 66,340 Medicare services from Dr. Eldawy across 42 procedure codes in 2024, for 848 Medicare patients. Medicare paid $699,170 for them.
Medicare services, 202466,340
Medicare patients848
Paid by Medicare$699,170
Procedure codes42
Dr. Eldawy's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 9,7162024: 35,244263%
- Other services
- 2023: 02024: 24,007
- Tests and treatments
- 2023: 2032024: 2,146957%
- Office and hospital visits
- 2023: 1,4202024: 1,78326%
- Lab and pathology
- 2023: 2132024: 1,597650%
- Surgery
- 2023: 2292024: 1,537571%
- Imaging
- 2023: 02024: 26
Where Dr. Eldawy's Medicare services took place, 2024
- In an office66,207100%
- In a facility1330%
Dr. Eldawy compared with the Florida median for medical oncologists, 2024
- Dr. Eldawy
- Florida median
- Medicare services
- 66,340vs 19,7553.4 times
- Medicare patients
- 848vs 54157% above
- Part D claims
- 809vs 59835% above
Medians across 462 medical oncologists in Florida with Dmand AI profiles that report each measure.
Dr. Eldawy's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Eldawy?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Eldawy and other medical oncologists in Florida.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Tarek Eldawy treated 848 Medicare patients in 2024, average age 76
CMS counts 848 Medicare patients who saw Dr. Eldawy in 2024. The largest group is 75 to 84, with 370 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Eldawy's median patient age at 68, with 65% women.
Medicare patients, 2024848
Average age76
Average risk score2.04
Also on Medicaid9%
Dr. Eldawy's Medicare patients by age, 2024
Dr. Eldawy's Medicare patients by sex, 2024
- Women53063%
- Men31838%
Chronic conditions among Dr. Eldawy's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis56%
- Ischemic heart disease43%
- Chronic kidney disease42%
- Diabetes39%
- Anxiety34%
- Cancer34%
Share of Medicare patients with each condition. A patient can have several.
Dr. Eldawy's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women65%
- Men34%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Tarek Eldawy wrote 1,066 Medicare Part D claims in 2024
In 2024, Dr. Eldawy wrote 1,066 Medicare Part D claims for 214 patients. 69% of them were for generic drugs. CMS names the drug for 809 of them, across 29 drugs with 11 or more claims each, at $2,211,689 in total drug cost. In 2023, CMS named 1,076 claims across 42 drugs.
Part D claims, 20241,066
Drugs named by CMS29
Total drug cost$2.2M
Part D patients214
Dr. Eldawy's Part D claims by kind of drug, 2024
- Generic734 claims69%
- Brand-name332 claims31%
Dr. Eldawy's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Eldawy's Part D claims, 2024
- Opioids10%102 of 1,066 claims
- Antibiotics3%30 of 1,066 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,0762024: 80925%
Drugs named by CMS: 29 in 2024, 42 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Tarek Eldawy takes part in Medicare
Dr. Eldawy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find medical oncologists like Dr. Eldawy by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Tarek Eldawy has worked on 2 clinical trials
Dmand AI links Dr. Eldawy to 2 clinical trials, 2 of them phase 3 studies. Conditions studied include Breast Neoplasms, Carcinoma, Non-Small-Cell Lung and Breast Diseases.
Conditions in Dr. Eldawy's trials
- Breast Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Breast Diseases
- Carcinoma, Bronchogenic
Investigators on the most trials with Dr. Eldawy
- Carlos A. Alemany, MD1 shared trial
- Thomas Carl Anderson, MD1 shared trial
- Mouni William Audeh, MD1 shared trial
Recent clinical trials with Dr. Eldawy
Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer (opens in a new tab)
TerminatedPhase 3
Carcinoma, Non-Small-Cell LungCarcinoma, BronchogenicErlotinibTivantinib
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Tarek Eldawy received $87,602 in industry payments from 2016 to 2025
CMS Open Payments shows 769 general payments to Dr. Eldawy from 74 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 57% of the total. AstraZeneca Pharmaceuticals LP paid the most, $15,889.
General payments to Dr. Eldawy by program year, 2016 to 2025
General payments to Dr. Eldawy by kind, 2016 to 2025
$87.6Kin total
- Consulting fees$49,91357%
- Food and beverage$19,26522%
- Travel and lodging$9,46211%
- Speaker and faculty fees$6,3807%
- Other$2,5823%
Companies that paid Dr. Eldawy the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Tarek Eldawy graduated from Alexandria University Faculty of Medicine
Dr. Eldawy graduated from Alexandria University Faculty of Medicine in 1989. Dr. Eldawy is a member of ASCO.
- Medical school
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Tarek Eldawy accepts plans from 19 insurance carriers
Dr. Eldawy is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.
- Aetna
- Blue Cross Blue Shield of Michigan
- Elevance
- United Healthcare
- Cigna
- Alliant Health Plans
- Aspirus Health Plan
- Blue Cross Blue Shield of Massachusetts
- +11 more carriersWith a free account
Plan types Dr. Eldawy accepts, by number of carriers
- PPO13
- HMO9
- Medicare8
- POS6
- EPO4
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Tarek Eldawy's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Tarek Eldawy
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Tarek Eldawy's NPI number?
Dr. Tarek Eldawy's NPI number is 1669416459. It was assigned on June 15, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Tarek Eldawy?
Dr. Tarek Eldawy is a medical oncologist in Cape Coral, Florida. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Tarek Eldawy practice?
Dr. Eldawy practices at 1708 Cape Coral W Pkwy, Cape Coral, FL 33914. Dr. Eldawy's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida. Dmand AI also links Dr. Eldawy to 1 hospital, 4 group practices and clinics and 3 medical groups.
What is Dr. Tarek Eldawy's office phone number?
The practice phone on file for Dr. Eldawy is (239) 541-4633.
What is Dr. Tarek Eldawy's medical license number?
Dr. Eldawy holds Florida license ME94574, one of the licenses on file in 2 states.
Which states has Dr. Tarek Eldawy been licensed in?
Dmand AI has state licenses on file for Dr. Eldawy in Florida (2005 to 2026) and Michigan (2000 to 2003).
Which hospitals is Dr. Tarek Eldawy affiliated with?
Dr. Eldawy is affiliated with AdventHealth Orlando. Dmand AI links Dr. Eldawy to 1 more hospital.
What medical group is Dr. Tarek Eldawy part of?
Dr. Eldawy is linked to Florida Cancer Specialists & Research Institute. Dmand AI links Dr. Eldawy to 3 more medical groups.
Does Dr. Tarek Eldawy accept Medicare?
Yes. CMS data shows Dr. Eldawy billed Medicare for 66,340 services in 2024, and Dr. Eldawy accepts Medicare assignment.
How many Medicare patients does Dr. Tarek Eldawy see?
CMS counts 848 Medicare patients who saw Dr. Eldawy in 2024, with an average age of 76.
Show 8 more questionsShow fewer questions
Is Dr. Tarek Eldawy board certified?
Yes. Dr. Eldawy is board certified in medical oncology by the American Board of Internal Medicine.
What services does Dr. Tarek Eldawy bill to Medicare?
In 2024, Dr. Eldawy's most billed Medicare services were medicare temporary code (Q0138), injected or infused drug (J1756) and injected or infused drug (J0897).
Where did Dr. Tarek Eldawy go to medical school?
Dr. Eldawy graduated from Alexandria University Faculty of Medicine in 1989.
What drugs does Dr. Tarek Eldawy prescribe most?
In 2024 Medicare Part D data, Dr. Eldawy's most prescribed drugs by claims were Eliquis, Revlimid and Anastrozole.
Has Dr. Tarek Eldawy received payments from drug or device companies?
CMS Open Payments shows $87,602 in general payments to Dr. Eldawy from 74 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Tarek Eldawy been practicing?
Dr. Eldawy graduated from medical school in 1989, 37 years ago.
Does Dr. Tarek Eldawy do research?
Dr. Eldawy has worked on 2 clinical trials.
What insurance does Dr. Tarek Eldawy accept?
Dr. Eldawy is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card